However, in one passage 2 cell culture that was not investigated in prior assays, we detected all three mutations that were found in the patient's tumor at high variant allele frequencies by MiSeq (81.3% mutant KRAS; Fig. 1d) and these cells gave rise to a tumor on subcutaneous injection in an NSG mouse (Fig. 2). Here, KRAS is linked to neoplasm.